{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1597339", "DateCompleted": {"Year": "1992", "Month": "07", "Day": "08"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0019-5499", "JournalIssue": {"Volume": "36", "Issue": "1", "PubDate": {"Year": "1992", "Month": "Jan"}}, "Title": "Indian journal of physiology and pharmacology", "ISOAbbreviation": "Indian J Physiol Pharmacol"}, "ArticleTitle": "Evidence for nootropic effect of BR-16A (Mentat), a herbal psychotropic preparation, in mice.", "Pagination": {"StartPage": "29", "EndPage": "34", "MedlinePgn": "29-34"}, "Abstract": {"AbstractText": ["BR-16A (Mentat 50-500 mg/kg) improved acquisition and retention of a passive avoidance task in a step-down paradigm in mice. BR-16A (50-500 mg/kg) reversed scopolamine (0.3 mg/kg)-induced disruption of acquisition and retention. BR 16-A (50 and 100 mg/kg) attenuated amnesia produced by the acute treatment with electroconvulsive shock (ECS), immediately after training. Chronic treatment with ECS, for 6 successive days at 24 h interval, disrupted memory consolidation on the 7th day. Daily administration of BR-16A (50 and 100 mg/kg) for 6 days significantly improved memory consolidation in mice receiving chronic ECS treatment. BR-16A (20-500 mg/kg), administered on the 7th day, also attenuated the disruption of memory consolidation produced by chronic treatment with ECS. On elevated plus-maze, BR-16A (50 and 100 mg/kg) reversed scopolamine (0.3 mg/kg)-induced delay in transfer latency on the 1st day. The above data suggests a nootropic effect of BR-16A in naive and amnesic mice."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Panjab University, Chandigarh."}], "LastName": "Kulkarni", "ForeName": "S K", "Initials": "SK"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Verma", "ForeName": "A", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "India", "MedlineTA": "Indian J Physiol Pharmacol", "NlmUniqueID": "0374707", "ISSNLinking": "0019-5499"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Mentat"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Psychotropic Drugs"}, {"RegistryNumber": "DL48G20X8X", "NameOfSubstance": "Scopolamine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Avoidance Learning"}, {"QualifierName": ["drug effects"], "DescriptorName": "Behavior, Animal"}, {"QualifierName": [], "DescriptorName": "Electroshock"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Latency Period, Psychological"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Memory"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Psychotropic Drugs"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Scopolamine"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1992", "Month": "1", "Day": "1"}, {"Year": "1992", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1992", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1597339"]}}]}